Tenax Therapeutics (TENX) Shares Outstanding (2010 - 2026)

Tenax Therapeutics (TENX) has 8 years of Shares Outstanding (Entity) data on file, last reported at $4635.0 in Q4 2020.

• For the quarter ending Q4 2020, Shares Outstanding (Entity) rose 9.99% year-over-year to $4635.0; the trailing twelve-month figure through Dec 2020 stood at $4635.0 (up 9.99% YoY), and the FY2020 full-year result was $4635.0, up 9.99% from the prior year.
• Shares Outstanding (Entity) retreated to $4635.0 in Q4 2020, from $7887.0 in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $7887.0 in Q3 2020 to a low of $879.0 in Q1 2016.
• A 5-year average of $2512.2 and a median of $912.5 in 2018 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) changed 0.0% in 2016 and surged 360.04% in 2019, its largest moves.
• Tracing TENX's Shares Outstanding (Entity) over 5 years: stood at $879.0 in 2016, then gained by 0.34% to $882.0 in 2017, then climbed by 10.88% to $978.0 in 2018, then surged by 330.88% to $4214.0 in 2019, then climbed by 9.99% to $4635.0 in 2020.
• Business Quant data shows TENX's Shares Outstanding (Entity) at $4635.0 in Q4 2020, $7887.0 in Q3 2020, and $6310.0 in Q2 2020.